Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium

Acta Pharmacologica Sinica

Volumn 29, Issue 9, 2008, Pages 1103-1108

  Chen, Chieh Fu ^a   Chiou, Wen Fei ^b   Zhang, Jun Tian ^c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c INSTITUTE OF MATERIA MEDICA   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Chemical components; Ginseng saponins; Ginsenosides; Panax ginseng; Panax quinquefolium; Pharmacological effects; Steaming ginseng

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CENTRAL STIMULANT AGENT; GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RB 3; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 2; PANAXAN A; PANAXAN B; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL COMPOSITION; DIABETES MELLITUS; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; GINSENG; HUMAN; NONHUMAN; PANAX QUINQUEFOLIUM; REVIEW; VASODILATATION; WOUND HEALING;

ANIMALS; HUMANS; PANAX; PHYTOTHERAPY; SAPONINS; SPECIES SPECIFICITY;

EID: 51349086818     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00868.x     Document Type: Review

References (79)

1. Zhao HZ, editor. Cyclopedia of Panax ginseng and American ginseng. Hong Kong : Rong-Zhai Publishers 1998. p 9. [In Chinese].
2. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2006. p. 587 91. [In Chinese].
3. Kiangsu Institute of Modern Medicine. Encyclopedia of Chinese Drug. Shanghai : Shanghai Scientific Technical Publication 1977. p 29 36, 850 1. [In Chinese].
4. State Administration of Traditional Chinese Medicine of the People's Republic of China. Zhong-Hua-Ben-Cao, Condensed edition. Shanghai : Shanghai Scientific Technical Publication 1996. p 1269 74, p 1301 5. [In Chinese].
5. Zhao HZ, editor. Cyclopedia of Panax ginseng and American ginseng. Hong Kong : Rong-Zhai Publishers 1998. p 249. [In Chinese].
6. Zhao HZ, editor. Cyclopedia of Panax ginseng and American ginseng. Hong Kong : Rong-Zhai Publishers 1998. p 223, p 231. [In Chinese].
7. Court WA, Reynolds LB, Hendel JG. Influence of root age on the concentration of ginsenosides of American ginseng (Panax quinque-folium). Can J Plant Sci 1996 76 : 853 5.
8. Tanaka O, Sakai R. Saponins of Ginseng and related plants. In : Herz W, Grisebach H (Editors). Progress in chemistry of organic natural products. Vienna : Spring-Verlag, 1984. p 1 76.
9. Yang CR, Zhou J, Tanaka O. Chemotaxanomic studies and the utilization of Panax species. Acta Bot Yunnanica 1988 Suppl. 1 : 47 62. [In Chinese].
10. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2006. p 486 7. [In Chinese].
11. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, et al. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolium roots. Planta Med 2007 73 : 669 74.
12. Assinewe VA, Baum BR, Gagnon D, Arnason JT. Phytochemistry of wild populations of Panax quinquefolium (North American ginseng). J Agric Food Chem 2003 51 : 4549 53.
13. Schlag EM, Mclntosh MS. Ginsenoside content and variation among and within American ginseng (Panax quinquefolium L.) populations. Phytochemistry 2006 67 : 1510 9.
14. Wills RBH, Du XW, Stuart DI. Changes in ginsenosides in Australian-grown American ginseng plants (Panax quinquefolium L.). Aust J Exp Agric 2002 42 : 1119 23.
15. Cui JF. Identification and quantification of ginsenosides in various commercial ginseng preparations. Eur J Pharmacol Sci 1995 3 : 77 85.
16. Ma YC, Luo M, Mally L, Doucer M. Distribution and proportion of major ginsenosides and quality control of ginseng products. Chin J Med Chem 1996 6 : 11 21.
17. Popovich DG, Kitts DD. Generation of ginsenosides Rg3 and Rh2 from North American ginseng. Phytochemistry 2004 65 : 337 44.
18. Li WK, Gu CG, Zhang HJ, Awang DVC, Fitzloff JF, Fong HHS, et al. Use of high-performance liquid chromatography-tandem mass spec-trometry to distinguish Panax ginseng L.A. Meyer (Asian ginseng) and Panax quinquefolium L. (North American ginseng). Anal Chem 2000 72 : 5417 22.
19. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 547 553. [In Chinese].
20. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 544. [In Chinese].
21. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 554, p 555. [In Chinese].
22. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 546. [In Chinese].
23. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 557. [In Chinese].
24. Li FY, editor. Panax ginseng and American ginseng. Beijing : Chinese Agriculture Scientech Press 2002. p 577. [In Chinese].
25. Chang Y, Huang WJ, Tien LT, Wang SJ. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol 2008 578 : 28 36.
26. Zhang JT, Chui DH, Chen CF, editors. The chemistry metabolism and biological activities of ginseng. Beijing : Chemical Industry Press 2006.
27. Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system J Compil 2007 13 : 381 404.
28. Tian JW, Fu FH, Geng MY, Jiang YT, Yang JX, Jiang WL, et al. Neuroprotective effect of 20(s)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett 2005 374 : 92 7.
29. Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, et al. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Intern Immnuopharmacol 2007 7 : 312 20.
30. Radad K, Gille G, Liu LL, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006 100 : 175 86.
31. Chow SY, Chen CF, Hu WS. Pharmacological studies on Chinese herbs with potential hypotensive, analgesic and/or antipyretic effects. Natl Sci Coun Month 1976 4 : 2341 4. [In Chinese].
32. Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, et al. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol 2000 35 : 135 41.
33. Han KH, Choe SC, Kim HS, Sohn DW, Nam KY, Oh BH, et al. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998 26 : 199 209.
34. Sung J, Han KH, Zo JH, Park HJ, Kim CH, Oh BH. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med 2000 28 : 205 16.
35. Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopa-naxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci 1995 56 : 1577 86.
36. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996 23 : 728 32.
37. Kim DN, Kim EM, Kang KW, Cho MK, Choi SY, Kim SG. Gin-senoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Br J Pharmacol 2003 140 : 661 70.
38. Nakajima S, Uchiyama Y, Yoshida K, Mizukawa H, Haruki E. The effect of ginseng radius rubra on human vascular endothelial cells. Am J Chin Med 1998 26 : 365 73.
39. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004 110 : 1219 25.
40. Park HJ, Lee JH, Song YB, Park KH. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull 1996 19 : 1434 9.
41. Lim J H, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, et al. Protection of ischaemic hippocampal neuron by ginsenosides Rb1, a.main ingredient of ginseng root. Neurosci Res 1997 28 : 191 200.
42. Liu ZX, Liu XC. Effect of ginsenoside Rb 1 and Re on cardiomyocyte apoptosis after ischemia and reperfusion in rats. Chin J Histochem Cytochem 2002 11 : 374 7. [In Chinese].
43. Smolinsk AT, Pestka JJ. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(l)(ginseng) and parthenolide (feverfew). Food Chem Toxicol 2003 41 : 1381 90.
44. Sun K, Wang CS, Guo J, Horie Y, Fang SP, Wang F, et al. Protective effects of ginsenoside Rbl, ginsenoside Rgl, and notoginsenoside Rl on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci 2007 81 : 509 18.
45. Ro JY, Ahn YS, Kim KH. Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. Int J Immunopharmacol 1998 20 : 625 41.
46. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK et al. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 2003 523-524 : 75 8.
47. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, et al. Inhibitory effect of ginsenoside Rb 1 and compound K on NO and prosta-glandin E2 biosynthesis of RAW 264.7 cells induced by lipopolysac-charide. Biol Pharm Bull 2005 28 : 652 6.
48. Shin HR, Kim JY, Yun TK, Morgan G, Vainio H. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 2000 11 : 565 76.
49. Yun TK, Lee YS, Lee YH, Kim SI, Yun HY Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci 2001 16 Suppl : S6 18.
50. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002 406 : 1 8.
51. Popovich DG, Kitts DD. Ginsenosides can inhibit proliferation and induce apoptosis in cultured leukemia and intestinal cells but effects vary according to the structure of the compounds. FASEB J 2003 17 : A762.
52. Helms S. Cancer prevention and therapeutics: Panax ginseng. Alter Med Rev 2004 9 : 259 74.
53. Yoo HH, Yokozawa T, Satoh A, Kang KS, Kim HY. Effects of ginseng on the proliferation of human lung fibroblasts. Am J Chin Med 2006 34 : 137 46.
54. Sohn JW, Lee CH, Chung DJ, Park SH, Kim IS, Hwang WI. Effect of petroleum of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells. Exp Mol Med 1998 30 : 47 51.
55. Suzuki Y, Hikino H. Mechanisms of hypoglycaemic activity of pa-naxans A and B, glycans of Panax ginseng roots: effects on plasma level, secretion, sensitivity and binding of insulin in mice. Phytother Res 1989 3 : 20 4.
56. Takaku T, Kameda K, Matsuura Y, Sekiya K, Okuda H. Studies on insulin-like substances in Korea red ginseng. Planta Med 1990 56 : 27 30.
57. Tchilian EZ, Zhelezarov IE, Hadjivanova CI. Effect of ginsenoside Rgl on insulin binding in mice liver and membranes. Phytother Res 1991 5 : 46 8.
58. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care 1995 18 : 1373 5.
59. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, et al. Antidi-abetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002 5 : 1851 8.
60. Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phyto-medicine 2002 9 : 254 8.
61. Dey L, Xie JT, Wang A, Wu J, Maleckar SA, Yuan CS. Antihypergly-cemic effects of ginseng: comparison between root and berry. Phyto-medicine 2003 10 : 600 5.
62. Xie JT, Mehandale SR, Wang A, Han AH, Wu JA, Osinski J, et al. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol Review 2004 49 : 113 17.
63. Xie JT, Mehandale SR, Li X, Quigg K, Wang X, Wang CZ, et al. An-tidiabetic effect of ginsenoside Re in db/db mice. Biochim Biophys Acta 2005 1740 : 319 25.
64. Xie JT, Mehandale S, Yuan CS. Ginseng and diabetes. Am J Chin Med 2005 33 : 397 404.
65. Cho WCS, Chang WS, Lee SKW, Leung AWN, Cheng CHK, Yue KKM. Ginsenoside Re of Panax ginseng possesses significant an-tioxidant and antihypelipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006 550 : 173 9.
66. Cho WC, Yip TT, Chung WS, Lee SK, Leung AW, Cheng CH, et al. Altered expression of serum protein in ginsenoside Re-treated diabetic rats defected by SELDI-TOF MS. J Ethnopharmacol 2006 108 : 272 9.
67. Chan RY, Chen WF, Guo DA, Wong MS. Estrogen-like activity of ginsenoside Rgl derived from Panax notoginseng. J Clin Endocrinol Metab 2002 87 : 3691 5.
68. Lee Y, Jin Y, Lin W, Ji S, Choi S, Jang S, et al. Ginsenoside-Rhl, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 2003 84 : 463 8.
69. Cho J, Park W, Lee S, Ahn W, Lee Y Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-α and β, independent of ligand binding. J Clin Endocrinol Metab 2004 89 : 3510 15.
70. Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull 2005 28 : 1903 8.
71. Nakaya Y, Mawatari K, Takahashi A, Harada, N, Hata A, Yasui S. The phytoestrogen ginsenoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways. J Med Invest 2007 54 : 381 4.
72. Yu J, Eto M, Akishita M, Kaneko A, Ouchi Y, Okahe T. Signaling pathway of nitric oxide production induced by ginsenoside Rbl in human aortic endothelial cells: A possible involvement of androgen receptor. Bichem Biophys Res Commu 2007 353 : 764 9.
73. Huang YC, Chen CT, Chen SC, Lai PH, Liang HC, Chang Y, et al. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 2005 22 : 636 46.
74. Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DTP, et al. Pharmacogenomics and the Yin/Yang actions of ginseng: antitumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007 2 : 6.
75. Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 1994 17 : 635 9.
76. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995 18 : 1197 202.
77. Shinkai K, Akedo H, Mukai M, Imamure F, Isoai A, Kobayashi M, et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 1996 87 : 357 62.
78. Tao H, Yao M, Zou S, Zhao D, Qiu H. Effect of angiogenesis inhibitor Rg3 on the growth and metastasis of gastric cancer in SCID mice. Zhoughua Waike Zazhi 2002 40 : 606 8. [In Chinese].
79. Kang XM, Zhang QY, Tong DD, Zhao W. Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3. Zhongguo Zhongxiyi Jiehe Zazhi 2002 25 : 730 3. [In Chinese].